SMILE & LASIK in Korea (2026): Costs, Quality, and the 3–5 Day Trip
The price table, sourced
| Procedure (both eyes) | Seoul, published | US, published average |
|---|---|---|
| LASEK | ₩1.3M–3.0M (~$950–2,200) | $4,400–4,800 (avg $2,200–2,400/eye) |
| LASIK | ₩1.3M–3.0M (~$950–2,200) | |
| SMILE | ₩2.1M–4.2M (~$1,550–3,100) | $6,000+ typical where offered |
| SMILE Pro (VISUMAX 800) | ₩3.6M–6.6M (~$2,650–4,850) | Rare, few US sites ran it before 2024 |
| EVO ICL | ₩4.0M–7.4M (~$2,950–5,450) | ~$4,935/eye ($10,000+ both) |
Seoul figures are each clinic’s own legally mandated non-covered fee disclosure (Medical Service Act Art. 45), published on the clinic’s site: B&VIIT Eye Center · EOS Eye Clinic. Compare any clinic on Korea’s national price-disclosure system, HIRA. US averages from Vision Center / LASIK.com; ICL ranges from CareCredit. We do not cite booking aggregators.
Read the range, not the floor. These are disclosed minimum–maximum bands, and the price you are quoted depends on your prescription and astigmatism. B&VIIT states its minimum applies to hospital staff and physician referrals — a walk-in patient should plan against the middle of the band, not the bottom. Aggregator sites routinely quote the floor as if it were the norm.
Why the quality argument holds
- Outcome data: 99% of eyes at 20/20 or better at 24 months in a 100-eye SMILE series for moderate-to-high myopia (Graefe's Archive, 2019); Korean multicenter 3-year LASIK cohort confirms long-term stability (PMC, 2021).
- The tech lands in Korea first: EVO ICL approved in Korea in 2013, nine years before the US FDA (STAAR, Healio). SMILE Pro ran commercially in Korea from 2023; FDA cleared it in January 2024 (ZEISS).
- Volume: SMILE is ~80% of Korea's refractive procedures vs a still-LASIK-centric US market (EyeWorld, 2025). Demand base: 96.5% myopia among Seoul 19-year-old males (Scientific Reports, 2017).
- Conservative screening: Korean pre-ops run 40–60 minutes of diagnostics, and rejection for thin corneas, dry eye, or retinal findings is routine. The exam decides, not the salesperson.
The trip, day by day
| Day | What happens |
|---|---|
| D-14 | Prescription pre-read and eligibility call, obvious disqualifiers screened before any flight (contact-lens holiday scheduled) |
| Day 1 | 40–60 min diagnostic battery + surgeon consult → same-day surgery when cleared (documented case: 9:00 exam, 14:00 surgery) |
| Day 2 | Next-day check, drops protocol in English |
| Day 3–5 | Buffer day, fly-home clearance, English records for your home optometrist |
Same-day pathway documented by US travel journalists (Chris & Sara, 2023, $2,100 all-in including exam, medication, interpretation).
Honest caveats
No national registry exists for refractive volumes. Refractive surgery is uninsured in Korea, so it never enters claims databases. Clinic claims like "550,000 cases" are self-reported and unaudited. Directional, not verified.
Not everyone qualifies. Thin corneas, severe dry eye, and retinal findings disqualify. A refusal is the screening system working.
Transient dry eye for weeks post-op is normal and worth planning around. And the ~$1,900 headline is standard SMILE; SMILE Pro is the ~$3,100 premium tier.